Ziglim-M 2 Tablets PR: A Combination for Effective Diabetes Management

Ziglim-M 2 tablets contain a combination of Glimepiride (2mg) and Metformin (500mg), both clinically proven agents for managing type 2 diabetes. This once-daily tablet provides targeted action on blood sugar regulation.

Glimepiride: A sulfonylurea medication that stimulates the release of insulin from pancreatic beta cells, assisting with glucose control.
Metformin: An oral biguanide used to lower blood glucose levels by reducing hepatic glucose production and enhancing peripheral glucose uptake.

Ziglim-M 2 tablets offer a convenient, single-dose solution for effectively managing type 2 diabetes symptoms and improving patient compliance. Always consult your healthcare professional before starting any new medication regimen.

Important Note: This product should not be used in individuals with known hypersensitivity to Glimepiride or Metformin. It's essential to follow the prescribed dosage instructions and seek immediate medical attention if experiencing any side effects.